Result of percutaneous coronary intervention after successful fibrinolysis
DOI:
https://doi.org/10.56294/hl2024.432Keywords:
acute myocardial infarction, percutaneous coronary angiography, fibrinolysisAbstract
Introduction: Acute myocardial infarction is the main cause of death among cardiovascular diseases and primary percutaneous coronary intervention is the treatment of choice in infarcted patients with ST segment elevation.
Objective: To describe the results in the application of percutaneous coronary intervention after successful fibrinolysis in patients with acute myocardial infarction.
Methods: Observational, descriptive and cross-sectional study in patients with acute myocardial infarction treated at the “Saturnino Lora Torres” Provincial Hospital in Santiago de Cuba, in the period from January 2019 to December 2021. The patients were chosen through sampling. non-probabilistic intentional type.
Results: The average age was 57 years, with a predominance of males (70%). The main risk factors were high blood pressure (49%), smoking (45%) and diabetes mellitus (35%). 78% of patients used aspirin in treatment, followed by ACE inhibitors. 91% 91% presented chest pain and dyspnea in 67%. The most frequent topographic presentations were anterior (35%), inferior (33%) and extensive (18%). 59% affected only one vessel and a stent was placed in 78% of the total.
Conclusions: The results showed insufficiencies in the adequate treatment of patients with acute myocardial infarction.
References
1. Callea G, Tarricone R, Lara AM. Economic evidence of interventions for acute myocardial infarction: a review of the literature. EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol [Internet]. agosto de 2012 [citado 15 de diciembre de 2021];8:P. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22917795/
2. Ralapanawa U, Kumarasiri PVR, Jayawickreme KP, Kumarihamy P, Wijeratne Y, Ekanayake M, et al. Epidemiology and risk factors of patients with types of acute coronary syndrome presenting to a tertiary care hospital in Sri Lanka. BMC Cardiovasc Disord [Internet]. diciembre de 2019 [citado 15 de diciembre de 2021];19(1):229. Disponible en: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-019-1217-x
3. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association. Circulation [Internet]. 3 de marzo de 2020 [citado 15 de diciembre de 2021];141(9). Disponible en: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000757
4. World Health Organization. World Health Statistics 2012 [Internet]. Ginebra, Suiza: World Health Organization; 2012 [citado 10 de agosto de 2021]. Disponible en: https://www.who.int/data/gho/data/themes/topics/topics-details/GHO/world-health-statistics
5. Estadísticas en Salud. Anuario Estadístico de Cuba. Año 2020 [Internet].LaHabana,Cuba: MINSAP; 2021 [citado 15 de diciembre de 2021]. Disponible en: https://temas.sld.cu/estadisticassalud/2021/08/11/anuario-estadistico-de-salud-2020/
6. Vesterinen P. Electrocardiographic repolarization variables in detecting myocardial infarction and ischemic injury: From body surface potential mapping to a single lead. octubre de 2007 [citado 15 de diciembre de 2021];9. Disponible en: https://www.semanticscholar.org/paper/Electrocardiographic-repolarization-variables-in-%3A-Vesterinen/29e23c28cb92ff52ff410c2d286d59ce68142e22
7. Akbari H, Asadikaram G, Vakili S, Masoumi M. Atorvastatin and losartan may upregulate renalase activity in hypertension but not coronary artery diseases: The role of gene polymorphism. J Cell Biochem [Internet]. junio de 2019 [citado 15 de diciembre de 2021];120(6):9159-71. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/jcb.28191
8. O’Gara PT, Kushner FG, Ascheim DD, Casey DE, Chung MK, de Lemos JA, et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation [Internet]. 29 de enero de 2013 [citado 15 de diciembre de 2021];127(4). Disponible en: https://www.ahajournals.org/doi/10.1161/CIR.0b013e3182742cf6
9. Levisman J, Price MJ. Update on the Guidelines for the Management of ST-Elevation Myocardial Infarction. Am J Cardiol [Internet]. marzo de 2015 [citado 15 de diciembre de 2021];115(5):3A-9A. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0002914915000326
10. Rios Navarro P, Pariona M, Urquiaga Calderón JA, Méndez Silva FJ. Características clínicas y epidemiológicas del infarto de miocardio agudo en un hospital peruano de referencia. Rev Peru Med Exp Salud Pública [Internet]. 24 de marzo de 2020 [citado 15 de diciembre de 2021];37(1):74-80. Disponible en: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/4527
11. World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA [Internet]. 27 de noviembre de 2013 [citado 15 de diciembre de 2021];310(20):2191-4. Disponible en: https://doi.org/10.1001/jama.2013.281053
12. Marcelo Garriga, Walter Rosales. Infarto Agudo de Miocardio: no todo se resuelve con mayor gasto [Internet]. Blog de Economía del Sector Público. 2019 [citado 15 de diciembre de 2021]. Disponible en: https://www.blogeconosp.econo.unlp.edu.ar/wp/2019/01/14/infarto-agudo-de-miocardio-no-todo-se-resuelve-con-mayor-gasto/
13. Martinez-Sanchez C, Borrayo G, Carrillo J, Juarez U, Quintanilla J, Jerjes-Sanchez C. Abordaje clínico y evolución hospitalaria en pacientes mexicanos con sindrome coronario agudo: El Tercer Registro Nacional de Síndromes Coronarios Agudos (RENASICA III). Arch Cardiol México [Internet]. septiembre de 2016 [citado 15 de diciembre de 2021];86(3):221-32. Disponible en: http://www.scielo.org.mx/scielo.php?script=sci_abstract&pid=S1405-99402016000300221&lng=es&nrm=iso&tlng=en
14. Fernandez-Avilés F, Alonso JJ, Castro-Beiras A, Vázquez N, Blanco J, Alonso-Briales J, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. The Lancet [Internet]. septiembre de 2004 [citado 15 de diciembre de 2021];364(9439):1045-53. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0140673604170591
15. Sánchez PL, Fernández-Avilés F. Angioplastia facilitada: ni blanco ni negro. Rev Esp Cardiol [Internet]. 1 de febrero de 2005 [citado 15 de diciembre de 2021];58(2):111-8. Disponible en: http://www.revespcardiol.org/es-angioplastia-facilitada-ni-blanco-ni-articulo-13071883
16. Arós F, Loma-Osorio Á, Bosch X, González Aracil J, López Bescós L, Marrugat J, et al. Manejo del infarto de miocardio en España (1995-99). Datos del registro de infartos de la Sección de Cardiopatía Isquémica y Unidades Coronarias (RISCI) de la Sociedad Española de Cardiología. Rev Esp Cardiol [Internet]. 1 de septiembre de 2001 [citado 15 de diciembre de 2021];54(9):1033-40. Disponible en: http://www.revespcardiol.org/es-manejo-del-infarto-miocardio-espana-articulo-13017795
17. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, et al. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol [Internet]. agosto de 2003 [citado 15 de diciembre de 2021];42(4):634-41. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0735109703007630
18. Bassand J-P, Danchin N, Filippatos G, Gitt A, Hamm C, Silber S, et al. Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. Eur Heart J [Internet]. 1 de diciembre de 2005 [citado 15 de diciembre de 2021];26(24):2733-41. Disponible en: https://doi.org/10.1093/eurheartj/ehi673
Published
Issue
Section
License
Copyright (c) 2024 Lucia Nivia Turro Mesa , Eloy Turro Caró, Rita María Mesa Valiente , Germán Del Río Caballero, Germán Ricardo Del Río Mesa, Margarita Montes de Oca Carmenaty (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
